Literature DB >> 10207064

Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription.

M E Martin1, A J Berk.   

Abstract

Adenovirus E1B 55,000-molecular-weight protein (55K) binds to host cell p53, stabilizing it, greatly increasing its affinity for its cognate DNA-binding site, and converting it from a regulated activator to a constitutive repressor. Here we analyzed the mechanism of repression by the p53-E1B 55K complex. E1B 55K repression requires that 55K be tethered to the promoter by binding directly to DNA-bound p53. Transcription from an assembled, p53-activated preinitiation complex was not repressed by the subsequent addition of E1B 55K, suggesting that either sites of 55K interaction with p53 or targets of 55K in the preinitiation complex are blocked. Specific E1B 55K repression was observed in reactions lacking TFIIA and with recombinant TATA-binding protein in place of TFIID, conditions under which p53 does not activate transcription. Thus, E1B 55K does not simply inhibit a p53-specific activation mechanism but rather blocks basal transcription. As a consequence, E1B 55K may repress transcription from any promoter with an associated p53-binding site, no matter what other activators associate with the promoter. E1B 55K did not repress basal transcription in reactions with recombinant and highly purified general transcription factors and RNA polymerase II but rather required a corepressor that copurifies with the polymerase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207064      PMCID: PMC84133          DOI: 10.1128/MCB.19.5.3403

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  82 in total

1.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

2.  Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.

Authors:  Y Wang; C Prives
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

3.  Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins.

Authors:  C C Kao; P R Yew; A J Berk
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

4.  Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography. Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody.

Authors:  N E Thompson; D B Aronson; R R Burgess
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

5.  Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.

Authors:  J Jayaraman; C Prives
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

6.  A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly.

Authors:  N Kobayashi; T G Boyer; A J Berk
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

7.  Repression of activator-mediated transcription by herpes simplex virus ICP4 via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB.

Authors:  B Gu; R Kuddus; N A DeLuca
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

8.  Association of an activator with an RNA polymerase II holoenzyme.

Authors:  C J Hengartner; C M Thompson; J Zhang; D M Chao; S M Liao; A J Koleske; S Okamura; R A Young
Journal:  Genes Dev       Date:  1995-04-15       Impact factor: 11.361

9.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

10.  Reversal of in vitro p53 squelching by both TFIIB and TFIID.

Authors:  X Liu; A J Berk
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  26 in total

1.  Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival.

Authors:  R W Johnstone; M Gerber; T Landewe; A Tollefson; W S Wold; A Shilatifard
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein.

Authors:  C Endter; J Kzhyshkowska; R Stauber; T Dobner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

3.  p53 Stimulates TFIID-TFIIA-promoter complex assembly, and p53-T antigen complex inhibits TATA binding protein-TATA interaction.

Authors:  J Xing; H M Sheppard; S I Corneillie; X Liu
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.

Authors:  D R Schwam; R L Luciano; S S Mahajan; L Wong; A C Wilson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7.

Authors:  Julia Kzhyshkowska; Andre Rusch; Hans Wolf; Thomas Dobner
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

6.  Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells.

Authors:  Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 7.  Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.

Authors:  Andrew N Blackford; Roger J A Grand
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription.

Authors:  Daniel L Miller; Brenden Rickards; Michael Mashiba; Wenying Huang; S J Flint
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

9.  Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.

Authors:  K Doronin; M Kuppuswamy; K Toth; A E Tollefson; P Krajcsi; V Krougliak; W S Wold
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

10.  Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx.

Authors:  Lisa Y Zhao; April L Colosimo; Yue Liu; Yanping Wan; Daiqing Liao
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.